Price T Rowe Associates Inc Zai Lab LTD Put Options Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ZLAB
# of Institutions
146Shares Held
53MCall Options Held
103KPut Options Held
439K-
Wellington Management Group LLP Boston, MA6.66MShares$225 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.57MShares$222 Million0.09% of portfolio
-
Capital World Investors Los Angeles, CA6.43MShares$217 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.17MShares$107 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$84.8 Million1.07% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.31B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...